Naoto Oku Selected Research

Naoto Oku Research Topics

Disease

83	Neoplasms (Cancer) 01/2023 - 01/2002
17	Neoplasm Metastasis (Metastasis) 02/2021 - 01/2002
12	Brain Ischemia (Cerebral Ischemia) 10/2023 - 05/2012
11	Seizures (Absence Seizure) 01/2013 - 09/2002
10	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2019 - 05/2012
10	Melanoma (Melanoma, Malignant) 01/2015 - 03/2008
9	Reperfusion Injury 10/2023 - 02/2009
9	Ischemia 01/2018 - 02/2009
8	Ischemic Stroke 02/2022 - 11/2015
8	Carcinoma (Carcinomatosis) 01/2018 - 06/2002
7	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 04/2003
7	Fibrosarcoma 02/2014 - 02/2005
6	Stroke (Strokes) 05/2017 - 05/2012
4	Inflammation (Inflammations) 10/2023 - 04/2014
4	Tetanus 01/2012 - 04/2010
4	Phototoxic Dermatitis (Phototoxicity) 11/2008 - 07/2003
3	Breast Neoplasms (Breast Cancer) 02/2021 - 06/2012
3	Dementia (Dementias) 01/2018 - 02/2008
3	Brain Neoplasms (Brain Tumor) 01/2011 - 05/2002
3	Glioma (Gliomas) 01/2011 - 05/2002
3	Epilepsy (Aura) 04/2004 - 09/2002
2	Infections 10/2023 - 01/2017
2	Triple Negative Breast Neoplasms 01/2023 - 01/2018
2	Sepsis (Septicemia) 01/2021 - 12/2017
2	Hyperglycemia 01/2021 - 01/2019
2	Cerebral Hemorrhage 01/2019 - 01/2017
2	Thrombosis (Thrombus) 01/2018 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 02/2008
2	Necrosis 01/2017 - 11/2008
2	Choroidal Neovascularization 01/2013 - 03/2011

Drug/Important Bio-Agent (IBA)

62	Liposomes (Liposome)IBA 01/2023 - 01/2002
24	Peptides (Polypeptides)IBA 01/2023 - 01/2002
16	ZincIBA 01/2013 - 05/2002
15	Small Interfering RNA (siRNA)IBA 01/2023 - 03/2007
14	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 04/2002
12	Neuroprotective AgentsIBA 02/2022 - 05/2012
12	alanyl-prolyl-arginyl-prolyl-glycineIBA 01/2016 - 04/2002
11	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2009 - 04/2003
10	Photosensitizing Agents (Photosensitizers)IBA 01/2009 - 01/2002
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 11/2004
9	Proteins (Proteins, Gene)FDA Link 10/2019 - 05/2007
9	Kainic Acid (Kainate)IBA 01/2009 - 05/2003
8	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018 - 03/2004
8	Triethylenephosphoramide (TEPA)IBA 01/2016 - 01/2011
7	Verteporfin (Visudyne)FDA Link 01/2009 - 04/2003
6	PolymersIBA 01/2023 - 03/2010
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2019 - 04/2010
5	Tacrolimus (Prograf)FDA LinkGeneric 05/2017 - 04/2013
5	Drug CarriersIBA 01/2017 - 11/2004
5	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 09/2003
5	Therapeutic UsesIBA 01/2016 - 02/2005
5	CholesterolIBA 01/2013 - 03/2004
4	fasudil (AT 877)IBA 10/2020 - 06/2016
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 11/2015
4	Matrix Metalloproteinase 14 (MT1-MMP)IBA 05/2007 - 09/2003
3	LigandsIBA 10/2023 - 10/2006
3	SolutionsIBA 02/2022 - 05/2002
3	nobiletinIBA 01/2018 - 01/2014
3	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2018 - 06/2012
3	Epidermal Growth Factor (EGF)IBA 01/2018 - 06/2012
3	Peptide LibraryIBA 05/2017 - 06/2002
3	LuciferasesIBA 02/2014 - 03/2011
3	arginyl-glycyl-aspartic acidIBA 01/2013 - 01/2005
3	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 06/2012 - 02/2004
3	TeaIBA 01/2011 - 09/2003
3	OligopeptidesIBA 01/2010 - 01/2005
3	Oxygen (Dioxygen)IBA 02/2009 - 05/2004
3	dpp-cndacIBA 05/2008 - 06/2002
3	EpitopesIBA 05/2007 - 01/2002
3	Glutamic Acid (Glutamate)FDA Link 08/2005 - 05/2003
2	CytokinesIBA 10/2023 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2011
2	Melitten (Melittin)IBA 01/2023 - 01/2021
2	Indicators and Reagents (Reagents)IBA 02/2021 - 10/2019
2	Histones (Histone)IBA 01/2021 - 12/2017
2	HydrogelsIBA 01/2021 - 10/2019
2	Radioisotopes (Radionuclides)IBA 01/2018 - 05/2002
2	Lipid NanoparticlesIBA 01/2018 - 07/2014
2	Antineoplastic Agents (Antineoplastics)IBA 05/2017 - 01/2005
2	InterferonsIBA 01/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 03/2007
2	tetraethylenepentamineIBA 01/2016 - 01/2013
2	sepantroniumIBA 01/2015 - 09/2014
2	TOR Serine-Threonine KinasesIBA 01/2015 - 01/2011
2	Heparin (Liquaemin)FDA LinkGeneric 07/2014 - 06/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2014 - 06/2012
2	Angiogenesis InhibitorsIBA 01/2013 - 03/2011
2	MicroRNAs (MicroRNA)IBA 01/2013 - 08/2011
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2013 - 01/2011
2	Erythropoietin FDA Link 12/2012 - 05/2012
2	NaphthoquinonesIBA 01/2012 - 10/2006

Therapy/Procedure

34	Therapeutics 10/2023 - 01/2002
10	Intravenous Injections 01/2023 - 05/2002
10	Drug Therapy (Chemotherapy) 01/2018 - 04/2002
9	Photochemotherapy (Photodynamic Therapy) 01/2009 - 01/2002
7	Lasers (Laser) 01/2009 - 03/2004
3	Thrombolytic Therapy 01/2019 - 11/2015
3	Injections 01/2015 - 04/2005
2	Intravenous Administration 06/2016 - 04/2013
2	Intravitreal Injections 01/2013 - 03/2011